More than 80% achieved at least 15% weight loss, supporting ongoing investigation in pharmacologic obesity management
Early data suggests Retatrutide may produce greater weight loss, but tirzepatide is currently FDA-approved and available in FloridaRetatrutide is not
Answer : The major players in the GLP-1 market include Novo Nordisk, Eli Lilly and Company, Zealand Pharma, Structure Therapeutics, Amgen, Viking Therapeutics, Sanofi, AstraZeneca, and Hansoh Pharmaceutical Group Co
A Phase 2a randomised trial published in Nature Medicine (2024) found that Retatrutide produced an 81.4% (8mg) and 82.4% (12mg) relative reduction in liver fat at 24 weeks, the most significant hepatic fat reduction recorded for a peptide of this class
With BCBS, Shapely patients can access medical weight loss support, including virtual visits with licensed providers, dietitian-led coaching, and prescriptions for weight loss medications
Dysesthesia refers to abnormal skin sensations including tingling, numbness, or unusual sensitivity to touch
